Christoph Rehmann-Sutter

The relationship of genes, genomes, the organism and the environment where development takes place can be explained in two dramatically different ways. The two views are characterized as ,,program theory' and ,,systemic theory' of DNA. The first assumes that genetic information is encoded in DNA and preexists development. Environmental influences are treated as conditions for adequate gene expression, sometimes as selective conditions for different developmental pathways. The second assumes that genetic information that makes a difference in development is generated in the developmental contexts themselves. Environment, according to this account, matters per se, as a distinct kind of causes in developmental systems. The laboratory, a place where person-independent reproducibility of observations is enacted, may act as a selective epistemological factor that makes the program approach more viable than the systemic. Other reasons for the inclination of 20th Century's genetics towards the program view however are rooted in an a priori metaphysical tradition that placed DNA in the role of the essential causa formalis for ontogeny. German Die Beziehung zwischen Genen, Genomen, Organismen und der Umwelt, in der die Entwicklung stattfindet, kann auf zwei dramatisch verschiedene Weisen erklärt werden. Diese beiden Ansichten werden charakterisiert als ,,ProgrammTheorie und als ,,systemische Theorie der DNA. Die erstere nimmt an, dass genetische Information in der DNA codiert ist und vor der Entwicklung schon existiert. Umwelteinfl-üsse werden als Bedingungen für eine adequate Gen expression behandelt, manche als selektive Bedingungen für die Auswahl zwischen verschiedenen Entwicklungswegen. Die zweite Ansicht nimmt an, dass genetische Information, die in der Entwicklung einen Unterschied macht, in den Kontexten der Entwicklung erst erzeugt wird. Die Umwelt ist gemäss diesem Ansatz per se wichtig, als eine eigene Art von Ursachen in sich entwickelnden Systemen. Das Laboratorium, ein Ort, in dem die personenunabhängige Reproduzierbarkeit von Beobachtungen inszeniert wird, kann als ein selek tiver epistemologischer Faktor angesehen werden, der die Programm-Sicht des Genoms favorisiert. Andere Gründe für die Neigung der Genetik des 20. Jahrhunderts zur Programm-Theorie liegen aber in einer metaphysischen Tradi tion, die der DNA die Rolle der essentiellen causa formalis für die Ontogenese verliehen hat.

Scientific knowledge is experimental knowledge. Such knowledge can be seen as "forbidden," either because the experiments leading to that knowledge are seen as immoral, or because interventions made possible by that knowledge could be morally offensive. There is currently an interesting case in the realm of genetic engineering, in which moral condemnations have been forthcoming but have not been unanimous. Here I present an analysis of this heterogeneity of moral assessment in the hope that this study of a single case might be helpful for the discussion of bioethical generalizations around the category of the "forbidden."

Health-care professionals in end-of-life care are frequently confronted with patients who seem to be ‘ambivalent’ about treatment decisions, especially if they express a wish to die. This article investigates this phenomenon by analysing two case stories based on narrative interviews with two patients and their caregivers. First, we argue that a respectful approach to patients requires acknowledging that coexistence of opposing wishes can be part of authentic, multi-layered experiences and moral understandings at the end of life. Second, caregivers need to understand when contradictory statements point to tensions in a patient’s moral experience that require support. Third, caregivers should be careful not to negatively label or even pathologize seemingly contradictory patient statements

The social interface between reproductive medicine and embryonic stem cell research has been investigated in a pilot study at a large IVF clinic in central China. Methods included observation, interviews with hospital personnel, and five in-depth qualitative interviews with women who underwent IVF and who were asked for their consent to the donation of embryos for use in medical (in fact human embryonic stem cell) research. This paper reports, and discusses from an ethical perspective, the results of an analysis of these interviews. The participants talked of extreme social pressure to become pregnant. Once they had a baby, ‘spare’ embryos lost practical significance due to the Chinese one-child policy. In the context of decision making about donating embryos to research, the women used the clinical distinctions between ‘good and bad quality’ embryos and also between frozen and transferred embryos, as guiding moral distinctions. In the absence of concrete information about what sort of research their embryos should be used for, the women interviewed either refused consent (for fear that the embryo would be given to another couple) or accepted, expressing motives of solidarity with other women in a similar situation. This reveals that they filled the knowledge gap with an image of research improving fertility treatment